Table 4.
Direct, indirect, and total effects of the study variables in model 2.
β | SE | Percentile 95% CI | Bias-corrected percentile 95% CI | P -value | |||
---|---|---|---|---|---|---|---|
Lower | Upper | Lower | Upper | ||||
Standardized direct effect | |||||||
Neuroticism → Medication adherence | −0.049 | 0.048 | −0.144 | 0.047 | −0.145 | 0.046 | 0.297 |
Self-efficacy → Medication adherence | 0.135 | 0.06 | 0.014 | 0.253 | 0.016 | 0.254 | 0.028* |
Social support → Medication adherence | 0.117 | 0.053 | 0.011 | 0.222 | 0.011 | 0.222 | 0.026* |
Neuroticism → Self-efficacy | −0.138 | 0.049 | −0.232 | −0.039 | −0.234 | −0.041 | 0.006** |
Social support → Self-efficacy | 0.314 | 0.062 | 0.193 | 0.435 | 0.188 | 0.433 | <0.001*** |
Neuroticism → Social support | −0.238 | 0.047 | −0.328 | −0.147 | −0.328 | −0.147 | <0.001*** |
Standardized indirect effect | |||||||
Neuroticism → Self-efficacy → Medication adherence | −0.019 | 0.012 | −0.045 | −0.001 | −0.05 | −0.003 | 0.018* |
Neuroticism → Social support → Medication adherence | −0.028 | 0.015 | −0.059 | −0.002 | −0.061 | −0.003 | 0.021* |
Neuroticism → Social support → Self-efficacy → Medication adherence | −0.01 | 0.006 | −0.023 | −0.001 | −0.025 | −0.002 | 0.016* |
Social support → Self-efficacy → Medication adherence | 0.043 | 0.022 | 0.004 | 0.089 | 0.006 | 0.092 | 0.021* |
Neuroticism → Social support → Self-efficacy | −0.075 | 0.022 | −0.124 | −0.037 | −0.126 | −0.039 | <0.001*** |
Standardized total effect | |||||||
Neuroticism → Medication adherence | −0.106 | 0.045 | −0.194 | −0.018 | −0.193 | −0.017 | 0.021* |
Social support → Medication adherence | 0.159 | 0.052 | 0.057 | 0.262 | 0.055 | 0.26 | 0.003** |
Neuroticism → Self-efficacy | −0.212 | 0.047 | −0.302 | −0.119 | −0.302 | −0.118 | <0.001*** |
Standardized estimating of 5,000 bootstrap sample. Age and gender were controlled. SE, standard error; CI, confidence interval.
Significant codes:
P < 0.001;
P < 0.01;
P < 0.05.